Table 5 Average participant performance for each trial phase and overall group performance.
Participant [Average MMSE score] | Phase | Mean number of steps completed independently (out of 5) | Mean number of interactions with human caregiver | Mean FAS* (out of 35) |
|---|---|---|---|---|
Severe-level dementia** | Â | Â | Â | Â |
S1 [4] | A1 | 0.1 | 14.1 | 2.4 |
| Â | B1 | 1.8 | 10.6 | 17.1 |
| Â | A2 | 0.6 | 16.2 | 7.3 |
| Â | B2 | 0.9 | 20.6 | 11.2 |
Moderate-level dementia | Â | Â | Â | Â |
S3 [15] | A1 | 5.0 | 0.0 | 35.0 |
| Â | B1 | 5.0 | 0.0 | 35.0 |
| Â | A2 | 4.9 | 0.2 | 34.8 |
| Â | B2 | 5.0 | 0.0 | 35.0 |
S4 [12] | A1 | 3.6 | 2.6 | 29.9 |
| Â | B1 | 5.0 | 0.0 | 34.7 |
| Â | A2 | 4.5 | 1.4 | 33.9 |
| Â | B2 | 5.0 | 0.0 | 34.5 |
S5 [20] | A1 | 3.3 | 4.4 | 30.7 |
| Â | B1 | 4.1 | 2.6 | 31.6 |
| Â | A2 | 3.8 | 3.8 | 32.2 |
| Â | B2 | 4.9 | 0.3 | 33.2 |
S6 [13] | A1 | 5.0 | 0.0 | 35.0 |
| Â | B1 | 5.0 | 0.0 | 34.9 |
| Â | A2 | 5.0 | 0.3 | 34.8 |
| Â | B2 | 5.0 | 0.0 | 34.9 |
S8 [11] | A1 | 4.6 | 1.9 | 33.2 |
| Â | B1 | 5.0 | 1.3 | 33.1 |
| Â | A2 | 4.5 | 2.2 | 32.8 |
| Â | B2 | 5.0 | 2.6 | 32.3 |
Mean score over phases for the moderate-level group | A1&A2 | 4.4 | 1.7 | 33.2 |
| Â | B1&B2 | 4.9 | 0.6 | 34.1 |
% change*** | Â | 11 | -66 | 2.4 |